Gene and Cell Therapy in Dental Tissue Regeneration

  1. Pablo Moreno, Juan Andrés de
  2. Serrano Ramos, Luis Javier
  3. García Arranz, Mariano Andrés
  4. Romeu, Luis
  5. Liras Martín, Antonio
Libro:
Human Tooth and Developmental Dental Defects - Compositional and Genetic Implications

ISBN: 978-1-83969-105-8

Año de publicación: 2021

Tipo: Capítulo de Libro

DOI: 10.5772/INTECHOPEN.97757 GOOGLE SCHOLAR lock_openAcceso abierto editor

Resumen

Advanced therapies hold substantial promise for the treatment of periodontal conditions. Gene therapy has the potential to transfer “therapeutic” genes, which express proteins such as bone morphogenetic proteins, osteoprotegerin, and tissue nonspecific alkaline phosphatase, which is deficient in patients with hypophosphatasia, a condition that affects mineralization of teeth and bone. Transferred genes may also express platelet-derived growth factor, which modulates the growth of periodontal tissue and the alveolar bone. As regards cell therapy, several clinical trials have shown that mesenchymal stem cells, when used with different kinds of scaffolds to enable the required three-dimensional environment, possess a bone regeneration potential that is particularly useful in such disorders as osteoporosis and osteonecrosis, or for regenerating alveolar bone (osseointegration) prior to placing a dental implant. However, much work is still required before these new therapies become true alternatives in routine clinical dental practice. Medical advances require investments, which are usually influenced by the priorities of both politicians and society at large. This will contribute to promoting innovation, efficient treatments, medium- and long-term savings, and a higher quality of life.

Referencias bibliográficas

  • European Commission. Regulation (EC) No 1394/2007 of the European Parliament and of the Council of 13 November 2007 on advanced therapy medicinal products and amending Directive 2001/ 83/EC and Regulation (EC) No 726/2004. Official Journal of the European Union 2007; 50(1): 121-137
  • Anguela XM, High KA. Entering the Modern Era of Gene Therapy. Annu Rev Med 2019; 70: 273-288. DOI: 10.1146/annurev-med-012017-043332
  • High KA, Roncarolo MG. Gene Therapy. N Engl J Med 2019; 381(5): 455-464. DOI: 10.1056/NEJMra1706910
  • Campbell A, Brieva T, Raviv L, Rowley J, Niss K, Brandwein H, et al. Concise Review: Process Development Considerations for Cell Therapy. Stem Cells Transl Med 2015; 4(10): 1155-1163. DOI: 10.5966/sctm.2014-0294
  • Zakrzewski W, Dobrzyński M, Szymonowicz M, Rybak Z. Stem cells: past, present, and future. Stem Cell Res Ther 2019; 10(1): 68. DOI: 10.1186/s13287-019-1165-5
  • Witten CM, McFarland RD, Simek SL. Concise Review: The U.S. Food and Drug Administration and Regenerative Medicine. Stem Cells Transl Med 2015; 4(12): 1495-1499. DOI: 10.5966/sctm.2015-0098
  • Trohatou O, Roubelakis MG. Mesenchymal Stem/Stromal Cells in Regenerative Medicine: Past, Present, and Future. Cell Reprogram 2017; 19(4): 217-224. DOI: 10.1089/cell.2016.0062
  • Li M, Izpisua JC. Organoids: Preclinical Models of Human Disease. N Engl J Med 2019; 380: 569-579. DOI: 10.1056/NEJMra1806175
  • Cui H, Nowicki M, Fisher JP, Zhang LG. 3D Bioprinting for Organ Regeneration. Adv Healthc Mater 2017; 6(1): 10.1002/adhm.201601118. DOI: 10.1002/adhm.201601118
  • Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, et al. Current Clinical Applications of In Vivo Gene Therapy with AAVs. Mol Ther 2020; S1525-0016(20)30664-X. DOI: 10.1016/j.ymthe.2020.12.007
  • Martínez-Molina E, Chocarro-Wrona C, Martínez-Moreno D, Marchal JA, Boulaiz H. Large-Scale Production of Lentiviral Vectors: Current Perspectives and Challenges. Pharmaceutics 2020; 12(11): 1051. DOI: 10.3390/pharmaceutics12111051
  • Harris E, Elmer JJ. Optimization of electroporation and other non-viral gene delivery strategies for T cells. Biotechnol Prog 2020; e3066. DOI: 10.1002/btpr.3066
  • Janik E, Niemcewicz M, Ceremuga M, Krzowski L, Saluk-Bijak J, Bijak M. Various Aspects of a Gene Editing System-CRISPR-Cas9. Int J Mol Sci 2020; 21(24): 9604. DOI: 10.3390/ijms21249604
  • Saw PE, Song EW. siRNA therapeutics: a clinical reality. Sci China Life Sci 2020; 63(4): 485-500. DOI: 10.1007/s11427-018-9438-y
  • Doss MX, Sachinidis A. Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications. Cells 2019; 8(5): 403. DOI: 10.3390/cells8050403
  • Berebichez-Fridman R, Montero-Olvera PR. Sources and Clinical Applications of Mesenchymal Stem Cells: State-of-the-art review. Sultan Qaboos Univ Med J 2018; 18(3): e264-e277. DOI: 10.18295/squmj.2018.18.03.002
  • Baniebrahimi G, Khanmohammadi R, Mir F. Teeth-derived stem cells: A source for cell therapy. J Cell Physiol 2019; 234(3): 2426-2435. DOI: 10.1002/jcp.27270
  • Shinde V, Sureshkumar P, Sotiriadou I, Hescheler J, Sachinidis A. Human Embryonic and Induced Pluripotent Stem Cell Based Toxicity Testing Models: Future Applications in New Drug Discovery. Curr Med Chem 2016; 23(30): 3495-3509. DOI: 10.2174/0929867323666160627113436
  • King NM, Perrin J. Ethical issues in stem cell research and therapy. Stem Cell Res Ther 2014; 5(4): 85. DOI: 10.1186/scrt474
  • EMA/468680/2018. Public summary of opinion on orphan designation ex-vivo fused autologous human bone marrow-derived mesenchymal stem cell with allogenic human myoblast for the treatment of Duchenne muscular dystrophy. 19 September 2018
  • Siemionow M, Szilagyi E, Cwykiel J, Domaszewska-Szostek A, Heydemann A, Garcia-Martinez J, et al. Transplantation of Dystrophin Expressing Chimeric (DEC) Human Cells of Myoblast/MSC Origin Improves Function in Duchenne Muscular Dystrophy Model. Stem Cells Dev 2021; 30(4): 190-202. DOI: 10.1089/scd.2020.0161
  • Zhang Y, Miron RJ, Li S, Shi B, Sculean A, Cheng X. Novel MesoPorous BioGlass/silk scaffold containing adPDGF-B and adBMP7 for the repair of periodontal defects in beagle dogs. J Clin Periodontol 2015; 42(3): 262-271. DOI: 10.1111/jcpe.12364
  • El-Sayed KMF, Dörfer CE. Animal Models for Periodontal Tissue Engineering: A Knowledge-Generating Process. Tissue Eng Part C Methods 2017; 23(12): 900-925. DOI: 10.1089/ten.TEC.2017.0130
  • Bozorgmehr M, Gurung S, Darzi S, Nikoo S, Kazemnejad S, Zarnani AH, et al. Endometrial and Menstrual Blood Mesenchymal Stem/Stromal Cells: Biological Properties and Clinical Application. Front Cell Dev Biol 2020; 8: 497. DOI: 10.3389/fcell.2020.00497
  • Kang YH, Lee HJ, Jang SJ, Byun JH, Lee JS, Lee HC, et al. Immunomodulatory properties and in vivo osteogenesis of human dental stem cells from fresh and cryopreserved dental follicles. Differentiation 2015; 90(1-3): 48-58. DOI: 10.1016/j.diff.2015.10.001
  • Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci 2019; 76: 3323-3348. DOI: 10.1007/s00018-019-03125-1
  • Nikfarjam S, Rezaie J, Zolbanin NM, Jafari R. Mesenchymal stem cell derived-exosomes: a modern approach in translational medicine. J Transl Med 2020; 18: 449. DOI: 10.1186/s12967-020-02622-3
  • Jiang W, Xu J. Immune modulation by mesenchymal stem cells. Cell Prolif 2020; 53(1): e12712. DOI: 10.1111/cpr.12712
  • Thomas M, Lotfi R, Gjerde C, Mustafa K, Veronesi E, Ahmed AB, et al. Translation of a standardized manufacturing protocol for mesenchymal stromal cells: A systematic comparison of validation and manufacturing data. Cytotherapy 2019; 21: 468-482. DOI: 10.1016/j.jcyt.2019.03.001
  • Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8(4): 315-317. DOI: 10.1080/14653240600855905
  • Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I, Marini FC, et al. Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7(5): 393-395. DOI: 10.1080/14653240500319234
  • Pham PV, Vu NB, Pham VM, Truong NH, Pham TLB, Dang LTT, et al. Good manufacturing practice-compliant isolation and culture of human umbilical cord blood-derived mesenchymal stem cells. J Transl Med 2014; 12: 56. DOI: 10.1186/1479-5876-12-56
  • Barckhausen C, Rice B, Baila S, Sensebé L, Schrezenmeier H, Nold P, et al. GMP-Compliant Expansion of Clinical-Grade Human Mesenchymal Stromal/Stem Cells Using a Closed Hollow Fiber Bioreactor. Methods Mol Biol 2016; 1416: 389-412. DOI: 10.1007/978-1-4939-3584-0_23
  • Tsuchiya S, Chiba M, Kishimoto KN, Nakamura H, Tsuchiya M, Hayashi H. Transfer of the bone morphogenetic protein 4 gene into rat periodontal ligament by in vivo electroporation. Arch Oral Biol 2017; 74: 123-132. DOI: 10.1016/j.archoralbio.2016.11.013
  • Park SY, Kim KH, Kim S, Lee YM, Seol YJ. BMP-2 Gene Delivery-Based Bone Regeneration in Dentistry. Pharmaceutics 2019; 11: 393. DOI: 10.3390/pharmaceutics11080393
  • Jin Q, Anusaksathien O, Webb SA, Printz MA, Giannobile WV. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004: 9: 519-526. DOI: 10.1016/j.ymthe.2004.01.016
  • Tang H, Mattheos N, Yao Y, Jia Y, Ma L, Gong P. In vivo osteoprotegerin gene therapy preventing bone loss induced by periodontitis. J Periodontal Res 2015; 50(4): 434-443. DOI: 10.1111/jre.12224
  • Mornet E. Hypophosphatasia. Metabolism 2018; 82: 142-155. DOI: 10.1016/j.metabol.2017.08.013
  • Choida V, Bubbear JS. Update on the management of hypophosphatasia. Ther Adv Musculoskel 2019; 11: 1759720X1986399. DOI: 10.1177/1759720X19863997
  • Bloch-Zupan A, Vaysse F. Hypophosphatasia: oral cavity and dental disorders. Arch Pédiatrie 2017; 24: 5S80-4. DOI: 10.1016/S0929-693X(18)30020-4
  • Bianchi ML, Bishop NJ, Guañabens N, Hofmann, Jakob F, Roux C, et al. Hypophosphatasia in adolescents and adults: overview of diagnosis and treatment. Osteoporos Int 2020; 31(8): 1445-1460. DOI: 10.1007/s00198-020-05345-9
  • Stürznickel J, Schmidt FN, Vopelius EV, Delsmann MM, Schmidt C, Jandl NM, et al. Bone healing and reactivation of remodeling under asfotase alfa therapy in adult patients with pediatric-onset hypophosphatasia. Bone 2021; 143: 115794. DOI: 10.1016/j.bone.2020.115794
  • Cahill RA, Wenkert D, Perlman SA, Steele A, Coburn SP, McAlister WH, et al. Infantile Hypophosphatasia: Transplantation Therapy Trial Using Bone Fragments and Cultured Osteoblasts. J Clin Endocrinol & Metabolism 2007; 92: 2923-2930. DOI: 10.1210/jc.2006-2131
  • Okawa R, Iijima O, Kishino M, Okawa H, Toyosawa S, Sugano-Tajima H, et al. Gene therapy improves dental manifestations in hypophosphatasia model mice. J Periodontal Res 2017; 52: 471-478. DOI: 10.1111/jre.12412
  • Ikeue R, Nakamura-Takahashi A, Nitahara-Kasahara Y, Watanabe A, Muramatsu T, Sato T, et al. Bone-Targeted Alkaline Phosphatase Treatment of Mandibular Bone and Teeth in Lethal Hypophosphatasia via an scAAV8 Vector. Mol Ther-Meth Clin D 2018; 10: 361-370. DOI: 10.1016/j.omtm.2018.08.004
  • Nakamura-Takahashi A, Tanase T, Matsunaga S, Shintani S, Abe S, Nitahara-Kasahara Y, et al. High-Level Expression of Alkaline Phosphatase by Adeno-Associated Virus Vector Ameliorates Pathological Bone Structure in a Hypophosphatasia Mouse Model. Calcif Tissue Int 2020; 106(6): 665-677. DOI: 10.1007/s00223-020-00676-5
  • Hirashima S, Kanazawa T, Ohta K, Nakamura KI. Three-dimensional ultrastructural imaging and quantitative analysis of the periodontal ligament. Anat Sci Int 2020; 95(1): 1-11. DOI: 10.1007/s12565-019-00502-5
  • Li A, Thomas RZ, van der Sluis L, Tjakkes GH, Slot DE. Definitions used for a healthy periodontium-A systematic review. Int J Dent Hyg 2020; 18(4): 327-343. DOI: 10.1111/idh.12438
  • Asa'ad F, Monje A, Larsson L. Role of epigenetics in alveolar bone resorption and regeneration around periodontal and peri-implant tissues. Eur J Oral Sci 2019; 127(6): 477-493. DOI: 10.1111/eos.12657
  • Zeng WY, Ning Y, Huang X. Advanced technologies in periodontal tissue regeneration based on stem cells: Current status and future perspectives. J Dent Sci 2021; 16(1): 501-507. DOI: 10.1016/j.jds.2020.07.008
  • Eggert FM, Levin L. Biology of teeth and implants: Host factors - pathology, regeneration, and the role of stem cells. Quintessence Int 2018; 49(6): 497-509. DOI: 10.3290/j.qi.a40289
  • Abukawa H, Terai H, Hannouche D, Vacanti JP, Kaban LB, Troulis MJ. Formation of a mandibular condyle in vitro by tissue engineering. J Oral Maxillofac Surg 2003; 61(1): 94-100. DOI: 10.1053/joms.2003.50015
  • Abukawa H, Shin M, Williams WB, Vacanti JP, Kaban LB, Troulis MJ. Reconstruction of Mandibular Defects with Autologous Tissue-Engineered Bone. J Oral Maxillofac Surg 2004; 62: 601-606. DOI: 10.1016/j.joms.2003.11.010
  • Streckbein P, Jäckel S, Malik CY, Obert M, Kähling C, Wilbrand JF, et al. Reconstruction of critical-size mandibular defects in immunoincompetent rats with human adipose-derived stromal cells. J Oral Maxillofac Surg 2013; 41(6): 496-503. DOI: 10.1016/j.jcms.2013.04.002
  • Compston JE, McClung MR, Leslie WD. Osteoporosis. Lancet 2019; 393(10169): 364-376. DOI: 10.1016/S0140-6736(18)32112-3
  • Cheng C, Wentworth K, Shoback DM. New Frontiers in Osteoporosis Therapy. Annu Rev Med 2020; 71(1): 277-288. DOI: 10.1146/annurev-med-052218-020620
  • Arjmand B, Sarvari M, Alavi-Moghadam S, Payab M, Goodarzi P, Gilany K, et al. Prospect of Stem Cell Therapy and Regenerative Medicine in Osteoporosis. Front Endocrinol 2020; 11: 430. DOI: 10.3389/fendo.2020.00430
  • Huijuan Liu, Xuechun Xia, Baojie Li. Mesenchymal stem cell aging: Mechanisms and influences on skeletal and non-skeletal tissues. Exp Biol Med (Maywood) 2015; 240(8): 1099-1106. DOI: 10.1177/1535370215591828
  • Li D, Zhou W, Cao M. Periostin-modified bone marrow mesenchymal stem cells from osteoporotic rats promote alveolar bone regeneration. J Mol Histol 2019; 50: 493-502. DOI: 10.1007/s10735-019-09843-x
  • Sui B, Hu C, Zhang X, Zhao P, He T, Zhou C, et al. Allogeneic Mesenchymal Stem Cell Therapy Promotes Osteoblastogenesis and Prevents Glucocorticoid-Induced Osteoporosis. Stem Cells Transl Med 2016; 5(9): 1238-1246. DOI: 10.5966/sctm.2015-0347
  • Kiernan J, Hu S, Grynpas MD, Davies JE, Stanford WL. Systemic Mesenchymal Stromal Cell Transplantation Prevents Functional Bone Loss in a Mouse Model of Age-Related Osteoporosis: MSC Transplantation Prevents Bone Loss. Stem Cells Transl Med 2016; 5(5): 683-693. DOI: 10.5966/sctm.2015-0231
  • Xu R, Fu Z, Liu X, Xiao T, Zhang P, Du Y, et al. Transplantation of osteoporotic bone marrow stromal cells rejuvenated by the overexpression of SATB2 prevents alveolar bone loss in ovariectomized rats. Exp Gerontol 2016; 84: 71-79. DOI: 10.1016/j.exger.2016.09.001
  • Chang J, Hakam AE, McCauley LK. Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw. Curr Osteoporos Rep 2018; 16(5): 584-595. DOI: 10.1007/s11914-018-0474-4
  • Anesi A, Generali L, Sandoni L, Pozzi S, Alexis Grande A. From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights. Int J Mol Sci 2019; 20(19): 4925. DOI: 10.3390/ijms20194925
  • He L, Sun X, Liu Z, Qiu Y, Niu Y. Pathogenesis and multidisciplinary management of medication-related osteonecrosis of the jaw. Int J Oral Sci 2020; 12(1): 30. DOI: 10.1038/s41368-020-00093-2
  • Melguizo-Rodríguez L, Costela-Ruiz VJ, Manzano-Moreno FJ, Ruiz C, Illescas-Montes R. Salivary Biomarkers and Their Application in the Diagnosis and Monitoring of the Most Common Oral Pathologies. Int J Mol Sci 2020; 21(14): 5173. DOI: 10.3390/ijms21145173
  • Vannala V, Palaian S, Shankar PR. Therapeutic Dimensions of Bisphosphonates: A Clinical Update. Int J Prev Med 2020; 11: 166. DOI: 10.4103/ijpvm.IJPVM_33_19
  • Srivastava A, Nogueras-Gonzalez GM, Geng Y, Won AM, Cabanillas ME, Naing A, et al. Prevalence of medication related osteonecrosis of the jaw in patients treated with sequential antiresorptive drugs: systematic review and meta-analysis. Support Care Cancer 2020. DOI: 10.1007/s00520-020-05882-3
  • Endo Y, Funayama H, Yamaguchi K, Monma Y, Yu Z, Deng X, et al. Basic Studies on the Mechanism, Prevention, and Treatment of Osteonecrosis of the Jaw Induced by Bisphosphonates. Yakugaku Zasshi 2020; 140(1): 63-79. DOI: 10.1248/yakushi.19-00125
  • Steel BJ. Management of Medication-related Osteonecrosis of the Jaw (MRONJ) risk in patients due to commence anti-resorptive/anti-angiogenic drugs - how should pre-drug-treatment dental preventive care be organised?. Community Dent Health 2019; 36(4): 244-254. DOI: 10.1922/CDH_4582Steel11
  • Wan JT, Sheeley DM, Somerman MJ, Lee JS. Mitigating osteonecrosis of the jaw (ONJ) through preventive dental care and understanding of risk factors. Bone Res 2020; 8: 14. DOI: 10.1038/s41413-020-0088-1
  • d’Aquino, R., De Rosa, A., Lanza, V., Tirino, V., Laino, L., Graziano, A., et al. Human mandible bone defect repair by the grafting of dental pulp stem/progenitor cells and collagen sponge biocomplexes. Eur Cell Mater 2009; 18(7): 75-83. DOI: 10.22203/ecm.v018a07
  • Li, Y., Xu, J., Mao, L., Liu, Y., Gao, R., Zheng, Z., et al. Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in swine. Stem Cells Dev 2013; 22(14): 2047-2056. DOI: 10.1089/scd.2012.0615
  • Barba-Recreo P, Del Castillo-Pardo JL, Georgiev-Hristov T, Bravo-Burguillos ER, Abarrategi A, Burgueño M, et al. Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model. J Craniomaxillofac Surg 2015; 43(7): 1161-1168. DOI: 10.1016/j.jcms.2015.04.026
  • Alonso-Rodriguez E, González-Martín-Moro J, Cebrián-Carretero JL, Del Castillo-Pardo L, Pozo-Kreilinger JJ, Ruiz-Bravo E, et al. Bisphosphonate-related osteonecrosis. Application of adipose-derived stem cells in an experimental murine model. Med Oral Patol Oral Cir Bucal 2019; 24(4): e529–e536. DOI: 10.4317/medoral.22959
  • U.S. National Library of Medicine. Use of Autologous Bone Marrow Stem Cells Seeded on Porous Tricalcium Phosphate Matrix and Demineralized Bone Matrix in Patients with Osteonecrosis (MSC/ONM). ClinicalTrials.govidentifier: NCT02566681. Available from: https://www.clinicaltrials.gov/ct2/show/NCT02566681?term=NCT02566681&draw=2&rank=1
  • Herdman M, Badia X, Berra S. EuroQol-5D: a simple alternative for measuring health-related quality of life in primary care. Aten Primaria 2001; 28(6): 425-430. DOI: 10.1016/s0212-6567(01)70406-4
  • Farzadmoghadam M, Mohammadi TM, Goudarzi R, Mohammadi M, Hasheminejad N. Is there a relationship between general and oral health-related quality of life in partially edentulous patients before and after implant treatment? A quasi-experimental study. Clin Oral Implants Res 2020; 31(6): 557-564. DOI: 10.1111/clr.13593
  • Gundestrup AK, Lynggaard CD, Forner L, Heino TJ, Jakobsen KK, Fischer-Nielsen A, et al. Mesenchymal Stem Cell Therapy for Osteoradionecrosis of the Mandible: a Systematic Review of Preclinical and Human Studies. Stem Cell Reviews and Reports 2020; 16: 1208-1221. DOI: 10.1007/s12015-020-10034-5
  • Matsuo A, Chiba H, Takahashi H, Toyoda J, Hasegawa O, Hojo S. Bone quality of mandibles reconstructed with particulate cellular bone and marrow, and platelet-rich plasma. J Craniomaxillofac Surg 2011; 39(8): 628-632. DOI: 10.1016/j.jcms.2011.01.003
  • Trautvetter W, Kaps C, Schmelzeisen R, Sauerbier S, Sittinger M. Tissue-engineered polymer-based periosteal bone grafts for maxillary sinus augmentation: five-year clinical results. J Oral Maxillofac Surg 2011; 69: 2753-2762. DOI: 10.1016/j.joms.2011.02.096
  • Matichescu A, Ardelean LC, Rusu LC, Craciun D, Bratu EA, Babucea M, et al. Advanced Biomaterials and Techniques for Oral Tissue Engineering and Regeneration-A Review. Materials (Basel) 2020; 13(22): 5303. DOI: 10.3390/ma13225303
  • Zheng C, Chen J, Liu S, Jin Y. Stem cell-based bone and dental regeneration: a view of microenvironmental modulation. Int J Oral Sci 2019; 11(3): 23. DOI: 10.1038/s41368-019-0060-3
  • Sui BD, Zheng CX, Li M, Jin Y, Hu CH. Epigenetic Regulation of Mesenchymal Stem Cell Homeostasis. Trends Cell Biol 2020; 30(2): 97-116. DOI: 10.1016/j.tcb.2019.11.006
  • Khayambashi P, Iyer J, Pillai S, Upadhyay A, Zhang Y, Tran SD. Hydrogel Encapsulation of Mesenchymal Stem Cells and Their Derived Exosomes for Tissue Engineering. Int J Mol Sci 2021; 22(2): E684. DOI: 10.3390/ijms22020684
  • Lee JWY, Bance ML. Physiology of Osseointegration. Otolaryngol Clin North Am 2019; 52(2): 231-242. DOI: 10.1016/j.otc.2018.11.004
  • Weng CC, Ou KL, Wu CY, Huang YH, Wang J, Yen Y, et al. Mechanism and Clinical Properties of StemBios Cell Therapy: Induction of Early Osseointegration in Novel Dental Implants. Int J Oral Maxillofac Implants 2017; 32(1): e47-e54. DOI: 10.11607/jomi.4460
  • Alqahtani NA, Chandramoorthy HC, Shaik S, Syed J, Chowdhary R, Antony L. Bone Marrow Mesenchymal Stromal Cells (BMMSCs) Augment Osteointegration of Dental Implants in Type 1 Diabetic Rabbits: An X-Ray Micro-Computed Tomographic Evaluation. Medicina (Kaunas) 2020; 56(4): 148. DOI: 10.3390/medicina56040148
  • Gan L, Liu Y, Cui D, Pan Y, Zheng L, Wan M. Dental Tissue-Derived Human Mesenchymal Stem Cells and Their Potential in Therapeutic Application. Stem Cells Int 2020; 1-17. DOI: 10.1155/2020/8864572
  • Xiao Z, Lei T, Liu Y, Yang Y, Bi W, Du H. The potential therapy with dental tissue-derived mesenchymal stem cells in Parkinson's disease. Stem Cell Res Ther 2021; 12(1): 5. DOI: 10.1186/s13287-020-01957-4
  • Shanbhag S, Suliman S, Pandis N, Stavropoulos A, Sanz M, Mustafa K. Cell therapy for orofacial bone regeneration: A systematic review and meta-analysis. J Clin Periodontol 2019; 46: 162-182. DOI: 10.1111/jcpe.13049
  • Vidal B, Pinto A, Galvão MJ, Santos AR, Rodrigues A, Cascão R, et al. Bone histomorphometry revisited. Acta Reumatol Port 2012; 37(4): 294-300. PMID: 24126421
  • Mehta S, Blagg R, Willcockson J, Gociman B, Yamashiro D, Siddiqi F. Cost-effectiveness analysis of demineralized bone matrix and rhBMP-2 versus autologous iliac crest bone grafting in alveolar cleft patients. Plast Reconstr Surg 2018; 142: 737-743. DOI: 10.1097/PRS.0000000000004646
  • Gjerde C, Mustafa K, Hellem S, Rojewski M, Gjengedal H, Yassin MA, et al. Cell therapy induced regeneration of severely atrophied mandibular bone in a clinical trial. Stem Cell Res Ther 2018; 9(1): 213. DOI: 10.1186/s13287-018-0951-9
  • U.S. National Library of Medicine. Reconstruction of Jaw Bone Using Mesenchymal Stem Cells. ClinicalTrials.govidentifier: NCT02751125. Available from: https://www.clinicaltrials.gov/ct2/show/NCT02751125?term=NCT02751125&draw=2&rank=1
  • Al-Jetaily S, Al-Dosari AA. Assessment of Osstell™ and Periotest® systems in measuring dental implant stability (in vitro study). Saudi Dent J 2011; 23(1): 17-21. DOI: 10.1016/j.sdentj.2010.09.003
  • U.S. National Library of Medicine. Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting (Maxibone). ClinicalTrials.govidentifier: NCT04297813. Available from: https://www.clinicaltrials.gov/ct2/show/NCT04297813?term=NCT04297813&draw=2&rank=1
  • Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: Which to use? Am J Emerg Med 2018; 36: 707-714. DOI: 10.1016/j.ajem.2018.01.008
  • Jacobs R, Salmon B, Codari M, Hassan B, Bornstein MM. Cone beam computed tomography in implant dentistry: recommendations for clinical use. BMC Oral Health 2018; 18: 88. DOI: 10.1186/s12903-018-0523-5
  • Liras A. Biological therapies for inherited diseases: social and bioethical considerations. Hemophilia as an example. Expert Opin Biol Ther 2015; 15: 713-722. DOI: 10.1517/14712598.2015.1029451
  • Staples RJ, Ivanovski S, Cedryck Vaquette. Fibre guiding scaffolds for periodontal tissue engineering. J Periodontal Res 2020; 55(3): 331-341. DOI: 10.1111/jre.12729
  • Liras A. Future research and therapeutic applications of human stem cells: general, regulatory, and bioethical aspects. J Transl Med 2010; 8: 131. DOI: 10.1186/1479-5876-8-131
  • Petrini C. Bioethics of Clinical Applications of Stem Cells. Int J Mol Sci 2017; 18: 814. DOI: 10.3390/ijms18040814
  • Bakopoulou A. Prospects of Advanced Therapy Medicinal Products-Based Therapies in Regenerative Dentistry: Current Status, Comparison with Global Trends in Medicine, and Future Perspectives. J Endod 2020; 46: S175-SS88. DOI: 10.1016/j.joen.2020.06.026
  • Watt RG, Daly B, Allison P, Macpherson LMD, Venturelli R, Listl S, et al. Ending the neglect of global oral health: time for radical action. Lancet 2019; 394: 261-272. DOI: 10.1016/S0140-6736(19)31133-X
  • Peres MA, Macpherson LMD, Weyant RJ, Daly B, Venturelli R, Mathur MR, et al. Oral diseases: a global public health challenge. Lancet 2019; 394: 249-260. DOI: 10.1016/S0140-6736(19)31146-8
  • Joshi C, Bapat R, Anderson W, Dawson D, Hijazi K, Cherukara G. Detection of periodontal microorganisms in coronary atheromatous plaque specimens of myocardial infarction patients: a systematic review and metanalysis. Trends Cardiovasc Med 2021; 31: 69-82. DOI: 10.1016/j.tcm.2019.12.005
  • Srivastava MC, Srivastava R, Verma PK, Gautam A. Metabolic syndrome and periodontal disease: an overview for physicians. J Family Med Prim Care 2019; 8: 3492-3495. DOI: 10.4103/jfmpc.jfmpc_866_19
  • Bagegni A, Abou-Ayash S, Rücker G, Algarny A, Att W. The influence of prosthetic material on implant and prosthetic survival of implant-supported fixed complete dentures: a systematic review and metanalysis. J Prosthodont Res 2019; 63: 251-265. DOI: 10.1016/j.jpor.2019.02.001
  • Shi X, Mao J, Liu Y. Pulp stem cells derived from human permanent and deciduous teeth: biological characteristics and therapeutic applications. Stem Cells Transl Med 2020; 9: 445-464. DOI: 10.1002/sctm.19-0398
  • Eder C, Wild C. Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption. J Mark Access Health Policy 2019; 7: 1600939. DOI: 10.1080/20016689.2019.1600939
  • Boráň T, Menezes-Ferreira M, Reischl I, Celis P, Ferry N, Gänsbacher B, et al. Clinical development and commercialization of advanced therapy medicinal products in the European Union: how are the product pipeline and regulatory framework evolving? Hum Gene Ther Clin Dev 2017; 28: 126-135. DOI: 10.1089/humc.2016.193
  • Pieri AD, Ribeiro S, Tsiapalis D, Eglin D, Bohner M, Dubruel P, et al. Joint academic and industrial efforts towards innovative and efficient solutions for clinical needs. J Mater Sci Mater Med 2018; 29: 129. DOI: 10.1007/s10856-018-6136-3
  • Regulation (EC) No. 1394/2007 of the European Parliament and of the Council on Advanced Therapy Medicinal Products and amending Directive 2001/83/EC and Regulation (EC) No. 726/ 2004. OJ L 2007; 324: 121-137
  • Directive 2009/120/EC amending Directive 2001/83/EC of the European Parliament and of the Council on the Community code relating to medicinal products for human use as regards advanced therapy medicinal products. OJ L 2009; 242: 3-12
  • Therapeutic goods administration, Australia’s regulatory framework for biological. [cited April 05, 2021]. Available from: http://www.tga.gov.au/industry/biologicals-framework.htm
  • Health Canada’s guidance document for cell, tissue and organ establishments safety of human cells, tissues and organs for transplantation. [cited April 05, 2021]. Available from: http://www.hc-sc.gc.ca/dhp-mps/brgtherap/reg-init/cell/cto_gd_ld-eng.php
  • FDA’s cellular therapy guidance documents. [cited April 05, 2021]. Available from: http://www.fda.gov/BiologicsBlood
  • Korea’s Ministry of Food and Drug Safety, Cell and Gene Therapy Products division. Regulation of Cell and Gene Therapy Products in Korea. [cited April 05, 2021]. Available from: https://www.mfds.go.kr/eng/wpge/m_22/de011012l001.do
  • Singapore’s Ministry of Health, Health Sciences Authority. Guidance on therapeutic product registration in Singapore [cited April 05, 2021]. Available from: https://www.hsa.gov.sg/content/hsa/en/Health_Products_Regulation/Western_Medicines/Overview/Guidelines_on_Drug_Registration.html
  • Japan Pharmaceutical Manufacturers Association, Regulatory Information Task Force. Pharmaceutical Administration and Regulations in Japan: Information on Japanese Regulatory Affairs. [cited April 05, 2021]. Available from: Japan: http://www.jpma.or.jp/english/parj/pdf/2019.pdf
  • Chisholm J, Crystal C, Viswanathan S. Current state of Health Canada regulation for cellular and gene therapy products: potential cures on the horizon. Cytotherapy 2019; 21(7): 686-698. DOI: 10.1016/j.jcyt.2019.03.005
  • Directive 2003/94/EC laying down the principles and guidelines of good manufacturing practice in respect of medicinal products for human use and investigational medicinal products for human use. OJ L 2003; 262: 22-26
  • Caplan AI, Mason C, Reeve B. The 3Rs of cell therapy. Stem Cells Transl Med 2017; 6: 17-21. DOI: 10.5966/sctm.2016-0180
  • Corbett MS, Webster A, Hawkins R, Woolacott N. Innovative regenerative medicines in the EU: a better future in evidence? BMC Med 2017; 15: 49. DOI: 10.1186/s12916-017-0818-4